Kruse Bo 4
4 · Y-mAbs Therapeutics, Inc. · Filed Nov 5, 2021
Insider Transaction Report
Form 4
Kruse Bo
DirectorEVP, CFO, Secy & Treas.
Transactions
- Sale
Common Stock
2021-11-04$27.54/sh−4,000$110,160→ 209,077 total
Footnotes (1)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2021.